Discogen is developing a treatment based on a ultrasound system that has been proven to stimulate and accelerate tissue repair and remodeling. This technology was proven safe and effective in a placebo controlled double-blinded study and was approved by the FDA. Discogen is refining this proven technology and applying it to the treatment of intervertebral discs to provide symptomatic relief of both low back and leg pain. Based on in vitro and in vivo studies, the Discogen system - DiscRx - is biologically active in reducing inflammation and promoting spinal disc tissue repair processes.